KRISTEN GRAHAM: Open Payments
NPI 1588207138 · LITCHFIELD PARK, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$944 in 43 payments from 15 companies in 2025. Trend: 2023 $834 · 2024 $1,118 · 2025 $944
Food & beverage: $944
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 10 | $195 |
| Regeneron Healthcare Solutions, Inc. | 6 | $167 |
| Novartis Pharmaceuticals Corporation | 3 | $91 |
| Galderma Laboratories, L.P. | 3 | $80 |
| LEO Pharma Inc. | 4 | $71 |
| ABBVIE INC. | 3 | $58 |
| BioWound Solutions, Inc. | 3 | $54 |
| KYOWA KIRIN, INC. | 2 | $50 |
| MIMEDX Group, Inc. | 2 | $45 |
| Janssen Biotech, Inc. | 2 | $42 |
Products named: DUPIXENT, LIBTAYO, SKYRIZI, bio-ConneKt, POTELIGEO, NEMLUVIO, TREMFYA, ADBRY.
Industry payments across AZ — which companies pay providers there.
